.svg){kind=small}
Mar-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the ever-evolving cannabis market, Foy has maintained a notable presence in the New York edibles category. Over the months from December 2024 to March 2025, Foy has consistently ranked within the top 20, fluctuating slightly from 16th to 19th place. This stability is indicative of a strong brand presence, although the slight dip in March suggests potential challenges or increased competition. Despite these fluctuations, Foy's sales figures have shown a moderate upward trend from January to March, indicating a recovery from the post-holiday sales slump typically seen in January. This resilience highlights Foy's ability to adapt and maintain consumer interest in a competitive market.
While Foy's presence in the New York edibles market remains strong, it is noteworthy that the brand has not appeared in the top 30 rankings for any other state or category during this period. This could be seen as a limitation in their market reach or an opportunity for growth and expansion. The lack of presence in other states could indicate a strategic focus on the New York market, or it might suggest potential areas for Foy to explore and expand their brand footprint. As the cannabis industry continues to grow, monitoring Foy's movements in other states and categories could provide insights into their strategic direction and potential for future growth.
Competitive Landscape
In the competitive landscape of the edible cannabis market in New York, Foy has experienced fluctuating rankings from December 2024 to March 2025, indicating dynamic competition. Foy's rank shifted from 16th in December 2024 to 19th by March 2025, suggesting a slight decline in its market position. Meanwhile, Kiva Chocolate consistently maintained a position within the top 20, albeit with a downward trend from 15th to 18th, which could reflect a similar challenge in maintaining market share. Notably, Happy Cabbage Farms showed a remarkable ascent from 51st to 21st, indicating a significant increase in sales momentum and potential threat to Foy's market share. Generic AF and The Bettering Company displayed relatively stable rankings, with Generic AF fluctuating slightly but ending stronger in March, while The Bettering Company improved its position from 22nd to 20th. These movements suggest that while Foy remains a key player, it faces increasing pressure from both established and emerging competitors, necessitating strategic adjustments to enhance its competitive edge.
Notable Products
In March 2025, Foy's top-performing product was the CBD/THC/CBN 1:1:1 Night Time Strawberry Adaptogen Chews 20-Pack, maintaining its number one rank from previous months with sales of 3,143 units. The CBD/THC/CBG 1:1:1 Daytime Mango Blood Orange Gummies 20-Pack also held steady at the second position, consistent with its performance since December 2024. The CBD Relief Cream, categorized as a topical, remained in third place, though its sales saw a notable decline to just 2 units in March, compared to 15 in February. This consistency in rankings suggests a stable consumer preference for these products. The sales figures indicate a slight decrease for the top-ranked chews compared to February, while the gummies experienced a slight sales increase.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
